Matarin Capital Management, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 185 filers reported holding REPLIGEN CORP in Q1 2017. The put-call ratio across all filers is 3.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2019$10,853,000
+16.6%
141,519
+30.7%
0.82%
+23.3%
Q2 2019$9,307,000
+682.1%
108,280
+437.5%
0.67%
+665.5%
Q1 2019$1,190,000
-100.0%
20,146
-72.8%
0.09%
-63.9%
Q3 2017$2,840,777,000
-29.3%
74,133
-23.5%
0.24%
-35.2%
Q2 2017$4,018,230,000
+20.4%
96,965
+2.3%
0.37%
+13.4%
Q1 2017$3,337,664,000
+19.5%
94,820
+4.6%
0.33%
+4.5%
Q4 2016$2,792,785,000
+3.1%
90,616
+1.0%
0.31%
+5.0%
Q3 2016$2,709,009,000
+15.1%
89,732
+4.3%
0.30%
-6.6%
Q2 2016$2,353,507,000
-12.2%
86,020
-14.0%
0.32%
-14.4%
Q1 2016$2,681,544,000
-40.3%
99,983
-37.0%
0.37%
-44.3%
Q4 2015$4,488,973,000
-16.5%
158,677
-17.8%
0.67%
-39.1%
Q3 2015$5,375,719,000
+8.3%
193,024
+60.5%
1.10%
-22.6%
Q2 2015$4,964,080,000
+48.8%
120,283
+9.5%
1.42%
+40.6%
Q1 2015$3,334,985,000
+75.8%
109,848
+14.6%
1.01%
+21.6%
Q4 2014$1,897,493,000
+1.7%
95,833
+2.3%
0.83%
-2.8%
Q3 2014$1,865,886,000
-12.6%
93,7160.0%0.86%
-9.9%
Q2 2014$2,135,788,000
+615.4%
93,716
+303.7%
0.95%
+440.3%
Q1 2014$298,558,000
+852922.9%
23,216
+454.2%
0.18%
+402.9%
Q2 2013$35,0004,1890.04%
Other shareholders
REPLIGEN CORP shareholders Q1 2017
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders